Creades (CRED) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Substantial value growth in 2024, with a 13% return on net asset value (NAV), outperforming OMXSGI's 9% and exceeding the absolute target of 7.5%.
Strong Q4 performance: NAV return of 3% versus OMXSGI's -6%.
Proposed dividend remains at SEK 1.60 per share, totaling SEK 217 mn, to be paid quarterly.
Portfolio rebalancing included Apotea's IPO and Creaspac's liquidation.
Financial highlights
Full-year NAV increased by SEK 991 mn after SEK 210 mn in dividends; NAV per share at SEK 75.
Net income for the year was SEK 1,202 mn (SEK 8.85 per share), up from SEK 558 mn (SEK 4.11 per share) year-over-year.
Q4 net income was SEK 287 mn (SEK 2.12 per share).
Solid cash position: SEK 717 mn in liquid assets at year-end, up from SEK 299 mn.
Equity increased to SEK 10,159 mn, with a 99% equity ratio.
Outlook and guidance
Management expects the current portfolio, with a tilt toward defensive growth, to perform well even in a weaker economic climate.
No significant post-balance sheet events reported.
Latest events from Creades
- NAV rose 12% in 2025, driven by listed assets, with key portfolio shifts and steady dividend.CRED
Q4 202522 Jan 2026 - NAV return +10% YTD, led by Avanza; Silex acquired, Stabelo sale agreed, strong cash position.CRED
Q3 202514 Oct 2025 - Net asset value rose 8% in H1 2025, led by Avanza and major portfolio transactions.CRED
Q2 202511 Jul 2025 - Substansvärdet steg 10% och resultatet förbättrades, men index överträffade utvecklingen.CRED
Q3 202413 Jun 2025 - Stark substansvärdetillväxt på 8% H1 2024, med noterade tillgångar som främsta drivkraft.CRED
Q2 202413 Jun 2025 - Q1 2025 NAV rose 2% with SEK 178m profit and a strategic Lumene Group investment.CRED
Q1 20256 Jun 2025